13
This is a list of the most frequently requested Non-Medicare rebatable tests.
Please contact (02) 9855 5400 for
clarification of the fee
and for details of other infrequently requested non-Medicare rebatable tests not listed here,
or
refer to specific test for Medicare criteria
. Patients are required to pay the amount in full, on receipt of the account
(which may be from a provider, other than DHMP).
Test
Hepatitis C PCR Qualitative
(HCV PCR Qual)
Medicare criteria:
Patient is Hepatitis C antibody positive or
Patient is Hepatitis C antibody status indeterminate or
To determine Hepatitis status in immunosuppressed or immunocompromised patient or
Detection of acute Hepatitis C prior to seroconversion when necessary for patient management or
Patient undertaking antiviral therapy for Hepatitis C
Hepatitis C PCR Quantitative
(HCV PCR Viral Load)
Medicare criteria:
Pre-treatment evaluation for antiviral therapy for chronic Hep C and test advised by specialist who manages treatment of the
patients hepatitis
12 week assessment on combination antiviral treatment
Hereditary Angioedema Type I + II
(C1 Esterase Gene Test)
Hereditary Angioedema Type III
(Factor XII HAE mutation Gene Test)
Histopathology ISH Testing
HLA-B1502
HLA-B5701
HLA-B5801
Holter Monitor
(24 hour)
Human Epididymis Protein 4
(HE4/ROMA)
Human Papilloma Virus DNA Typing
(HPV)
Medicare criteria:
Post-treatment for HSIL (CIN 2 or 3)
Inhibin B
Insect/Worm/Parasite Identification
(ICPMR)
Interleukin 6
Iodine – Urine Random or 24 hour
ISAC Microarray Allergen Testing
KRAS and NRAS screen
(Genetic test)
Medicare criteria:
Test of tumour tissue from a patient with metastatic colorectal cancer requested by, or on behalf of, a specialist or consultant
physician to determine if the requirements relating to Kirsten ras (KRAS) gene mutation status for access to cetuximab under the
PBS are fulfilled.
Kryptopyrroles – Urine Random
Separate bill from testing laboratory will be sent direct to patient.
LDL Fractionation
Leptin




